You’ve just added your first Follow! This is a brand new feature that will be at the core of several new tools and personalized information feeds that are coming soon.
Please continue to add stocks to your Follow list so that when the new tools and feeds roll out, you’ll immediately get to make use of them! We will alert early adopters of the Follow list to these new features first.
Aortech Share Chat (AOR)
|Share Name||Share Symbol||Market||Type||Share ISIN||Share Description|
|Aortech International||LSE:AOR||London||Ordinary Share||GB0033360586||ORD 5P|
|Price Change||% Change||Share Price||Bid Price||Offer Price||High Price||Low Price||Open Price||Shares Traded||Last Trade|
|Industry Sector||Turnover (m)||Profit (m)||EPS - Basic||PE Ratio||Market Cap (m)|
|Health Care Equipment & Services||0.8||-0.3||-7.7||-||1.33|
Aortech Share Discussion Threads
|bbr391 - You seems a knowledgeable sort of guy...have you heard how the heart valve project is going?||gac141|
|Still ongoing .||bbr391|
|Anyone have any ideas on the legal action status please?||semper vigilans|
|Oh yes and when we all thought the writing was on the wall and Aortech was bust how much of your money did you chance David? This money saved Aortech....||gac141|
|I see Xmas coming early for loan note holders. Shocking really, but to be expected from AIM listed companies these days.||cocker|
|Very disappointing revenue figures below last years interims Lets hope litigation is not being used as an excuse for poor sales focus. Have to say I believe Harrogate has summed up the current situation very well in his previous post Let us hope the directors are fully focussed on unlocking shareholder value I do not think there has been any change in that potential value but we do need to stay in business long enough to unlock that value ! No more banana skins would be appreciated||spurious|
|Aortech issued its Interim results and reported that trading for the 6 months to 30 September 2015 was in line with expectations and that after amortisation and exceptionals the reported operating loss was $193,000.
Much of the Chairman’s statement was taken with describing the potential for the set up of a new company to take forward AorTech’s heart valve technology - could this potentially unlock some of the value here in this AIM minnow, valued at just £1.2 million?
See more at: hTTp://tinyurl.com/o||investorschampion|
|why the sudden drop here, I wonder. No news about, no heavy selling that I'm aware of. MMs trying clear out weak holders before some good news is announced? Or have they got wind of bad news? Possibly it's neither.. just random market movements.||shrout|
|Yes......25th October seems to be a significant date!||tadders2|
|AorTech International PLC v. Folda The case against the Ex . Should provide our next uplift . The future is bright as long as the current board play the cards right . Good luck all And May||bbr391|
|Hi Gents - thanks for the notes - I am perhaps always as a long standing shareholder ( 1999) just too beaten up to believe all that yet - Hope you are right/ Thanks||harrogate|
|Harrogate As a fellow shareholder of longstanding (some may say long suffering)I understand your caution I am not noted for wild bouts of optimism particularly with Aor however I do recognise a fundamental shift both in sentiment and in what has been achieved over the last 12 months. I feel we are at an inflexion point for the share price which as we all know tends to anticipate events well in advance 12 month results pointed to a profitable stable company now crucially happy with its renegotiated relationship with Biomerics, confident in a ring fenced litigation process and now fully focused in releasing shareholder value through expanding its licencees and at long last attempting to realise the massive opportunity offered by its heart valve( backed by extensive patent protection). Let us wait for the evidence but the signs are already there. Once the evidence is out there the share price will imo be north of £1 and an opportunity missed. The tiny £2m current market cap imo offers a risk/reward ratio substantially in favour of the investor. That value is what I am trying to highlight.It would seem I am not alone Let us hope I am right Regards SP||spurious|
|Harrogate You are correct that there would appear to be masses of work to do, but reading the last statement would suggest that the outcome of that work should be positive. The IP position is better than 1999, there are 3 generations of patent filings since then some very recent. The key to value would seem to be can they identify a credible team to take the project forward?||landy90|
|On Tip TV today..
After the crash Zak identifies the top 10 shares to buy TODAY for the autumn in his new book published 1st September. Get your free copy HERE
Aortech International (AOR): 70p Price Channel Destination
It has not exactly been a pleasant ride in terms of the daily chart progression over the past couple of years. This is a point witnessed by the decline seen from 130p plus in the autumn of 2013, to a probe below 20p in March. Since then there has been a rehabilitation process, one which has involved higher support points since the spring above 20p, and hen the recovery of the 50 day and 200 day moving averages both currently at 28p.
The implication now in the wake of this extended base building is that the bulls should be happy to enjoy the latest golden cross buy signal between the 50 day and 200 day moving averages, with the message being that provided there is no end of day close back below these lines we should be wedded to the buy argument. Just how high the stock could fly over the next 1-2 months is suggested by the top of a rising trend channel, one which has been in place from as long ago as June last year. The best way forward on this basis would be to buy into Aortech International shares on any initial weakness which cools off the overbought RSI, now at 83.
- See more at: http://www.shareprop||gac141|
|It is great that we no longer seem to be at death's door but we should also not get carried away. The £3 share price of 3 years ago was really down to the value we felt we added to St Jude on the leads which turned out to be a complete illusion. My reading of the last RNS was that in terms of any real data on the heart valve we are back to 1999 almost and that there is a massive amount of work to do and won't any IP protection have lapsed by now? I also have not seen any evidence as you say above that " we are rapidly building turnover" there has been little evidence of new licenses of our technology. I am a lot more confident than I was 12 months ago but lots to do. Let's hope the management team are up to it - the are clearly good at fire fighting but that is a different kettle of fish.||harrogate|
Whether we get an update on progress at the agm or whether that comes some weeks later I am confident we will get news confirming we are in an exciting new chapter built on solid profitable foundations
As you point out people forget that the heart valve did represent a £32 million opportunity and if sold on to a major player after successful in house testing/validation/r||spurious|
|I hope you are right.. P I think we may have to be more patient... although any good news could move things very quickly. The building blocks have been put in place.||gac141|
|Have to echo your sentiments George. I am hoping the agm this month may provide the ideal opportunity for some positive news. Just as the downside on the share price was greatly exaggerated, the corresponding effect on any positive news will be an equally swift and strong rise I am confident we will see a share price well in excess of £1 in a matter of weeks. Value will out||spurious|
|Well said gac141.||tadders2|
|Aortech are clearly very much on their feet again and the prospect of insolvency has virtually disappeared. The market cap on this company is ridiculous bearing in mind what they have to offer. Elasteon and its other derivatives are amongst the best products for in body use anywhere in the world. We also have the heart valve which at one point st Jude medical were going to pay 32 million for. Again I congratulate Roy and Eddie for the tireless work they have put in to saving the company from the clutches of despicable businesses and people who were corrupt to the core. I once again look forward to Aortech being a valued company and an excellent asset to my portfolio. Good times ahead.......?||gac141|
|Hi Paul I regret selling Ind way too early, albeit at a good profit and well done for being so patient Biomerics relationship is key and for the first time this appears to be working. I am very hopeful we will see the benefits of this shortly in new increased repeat orders for Elasteon. Throw in a possible JV on the heart valve and a company confident in successfully pursuing a million dollar claim and you certainly have the makings of a multi-bagger. Aor enjoyed a share price in excess of £3 in last couple of years while loss making. It is now making profit. I am confident the share price will soon respond Best regards Patrick||spurious|
|Hi Patrick, I'm still in IND - 11 years now lol! This is a nice little summary of Aortech, from its most recent results statement: "Despite the time and commitment required in the litigation action, the past year has been one of relative success. Revenue from license fees and royalties are now greater than overheads, the Company was cash positive in the second half of the year, progress is being made with our key licensees and we expect the year 2015/16 to be one of further progress." Not bad for a mkt cap of only about £1.6m. PP.||paulypilot|